Dr. Reddy’s Laboratories Reports Q2 Revenue Growth
PremiumCompany AnnouncementsDr. Reddy’s Laboratories Reports Q2 Revenue Growth
5d ago
Dr. Reddy’s Announces New Employee Stock Options
Premium
Company Announcements
Dr. Reddy’s Announces New Employee Stock Options
6d ago
Journey Medical announces U.S. FDA approval of Emrosi
Premium
The Fly
Journey Medical announces U.S. FDA approval of Emrosi
6d ago
Dr. Reddy’s Faces Legal Challenges in US Antitrust Case
PremiumCompany AnnouncementsDr. Reddy’s Faces Legal Challenges in US Antitrust Case
26d ago
Dr. Reddy’s launches employee support program focused on menopause
Premium
The Fly
Dr. Reddy’s launches employee support program focused on menopause
27d ago
Dr. Reddy’s Announces Subsidiary’s Liquidation
Premium
Company Announcements
Dr. Reddy’s Announces Subsidiary’s Liquidation
1M ago
Dr. Reddy’s signs licensing agreement with Gilead for lenacapavir in India
PremiumThe FlyDr. Reddy’s signs licensing agreement with Gilead for lenacapavir in India
1M ago
Dr. Reddy’s Expands Access to HIV Treatment
Premium
Company Announcements
Dr. Reddy’s Expands Access to HIV Treatment
1M ago
Dr. Reddy’s Subsidiary Chirotech Dissolved
Premium
Company Announcements
Dr. Reddy’s Subsidiary Chirotech Dissolved
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100